Invariant NKT cell development requires a full complement of functional CD3 ζ immunoreceptor tyrosine-based activation motifs

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 6822-6832

  Becker, Amy M ^a   Blevins, Jon S ^b   Tomson, Farol L ^b   Eitson, Jennifer L ^a   Medeiros, Jennifer J ^a   Yarovinsky, Felix ^a   Norgard, Michael V ^b   Van Oers, Nicolai S C ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD3 ZETA ANTIGEN; KRUPPEL LIKE FACTOR 6; PHENYLALANINE; PROMYELOCYTIC LEUKEMIA PROTEIN; TYROSINE; UNCLASSIFIED DRUG; CD3 ANTIGEN, ZETA CHAIN; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA BURGDORFERI; CELL COUNT; CELL EXPANSION; CELL MATURATION; CELL SELECTION; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE RESPONSE; INVARIANT NATURAL KILLER CELL; LIVER; LYME DISEASE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SPLEEN; THYMUS; WILD TYPE; ANIMAL; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER T CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD3; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; INTERLEUKIN-4; LYME DISEASE; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77953628836     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902058     Document Type: Article

References (69)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
2. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417.
3. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
4. Godfrey, D. I., S. Stankovic, and A. G. Baxter. 2010. Raising the NKT cell family. Nat. Immunol. 11: 197-206.
5. Kumar, H., A. Belperron, S. W. Barthold, and L. K. Bockenstedt. 2000. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165: 4797-4801.
6. Tupin, E., M. R. Benhnia, Y. Kinjo, R. Patsey, C. J. Lena, M. C. Haller, M. J. Caimano, M. Imamura, C. H. Wong, S. Crotty, et al. 2008. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 105: 19863-19868.
7. Guo, J., A. Hawwari, H. Li, Z. Sun, S. K. Mahanta, D. R. Littman, M. S. Krangel, and Y. W. He. 2002. Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes. Nat. Immunol. 3: 469-476.
8. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716.
9. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971-978.
10. Benlagha, K., D. G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202: 485-492.
11. Chiu, Y. H., J. Jayawardena, A. Weiss, D. Lee, S. H. Park, A. Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189: 103-110.
12. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626. (Pubitemid 27516281)
13. Borowski, C., and A. Bendelac. 2005. Signaling for NKT cell development: the SAP-FynT connection. J. Exp. Med. 201: 833-836.
14. Nunez-Cruz, S., W. C. Yeo, J. Rothman, P. Ojha, H. Bassiri, M. Juntilla, D. Davidson, A. Veillette, G. A. Koretzky, and K. E. Nichols. 2008. Differential requirement for the SAP-Fyn interaction during NK T cell development and function. J. Immunol. 181: 2311-2320.
15. Chung, B., A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan. 2005. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174: 3153-3157.
16. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei, A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762. (Pubitemid 350102258)
17. Jordan, M. A., J. M. Fletcher, D. Pellicci, and A. G. Baxter. 2007. Slamf1, the NKT cell control gene Nkt1. J. Immunol. 178: 1618-1627.
18. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons, S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11: 340-345.
19. Pasquier, B., L. Yin, M. C. Fondanèche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201: 695-701.
20. Pitcher, L. A., M. A. Mathis, S. Subramanian, J. A. Young, E. K. Wakeland, P. E. Love, and N. S. van Oers. 2005. Selective expression of the 21-kilodalton tyrosine-phosphorylated form of TCR zeta promotes the emergence of T cells with autoreactive potential. J. Immunol. 174: 6071-6079.
21. Pitcher, L. A.,M. A.Mathis, J. A. Young, L. M. DeFord, B. Purtic, C.Wulfing, and N. S. van Oers. 2005. The CD3 gamma epsilon/delta epsilon signaling module provides normal T cell functions in the absence of the TCR zeta immunoreceptor tyrosine-based activation motifs. Eur. J. Immunol. 35: 3643-3654.
22. Pitcher, L. A., and N. S. C. van Oers. 2003. T-cell receptor signal transmission: who gives an ITAM? Trends Immunol. 24: 554-560.
23. Love, P. E., J. Lee, and E. W. Shores. 2000. Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection. J. Immunol. 165: 3080-3087.
24. Negishi, I., N. Motoyama, K.-I. Nakayama, K. Nakayama, S. Senju, S. Hatakeyama, Q. Zhang, A. C. Chan, and D. Y. Loh. 1995. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376: 435-438.
25. Wiest, D. L., J. M. Ashe, T. K. Howcroft, H.-M. Lee, D. M. Kemper, I. Negishi, D. S. Singer, A. Singer, and R. Abe. 1997. A spontaneously arising mutation in the DLAARN motif of murine ZAP-70 abrogates kinase activity and arrests thymocyte development. Immunity 6: 663-671.
26. Berg, L. J., L. D. Finkelstein, J. A. Lucas, and P. L. Schwartzberg. 2005. Tec family kinases in T lymphocyte development and function. Annu. Rev. Immunol. 23: 549-600.
27. Felices, M., and L. J. Berg. 2008. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J. Immunol. 180: 3007-3018.
28. Lazarevic, V., A. J. Zullo, M. N. Schweitzer, T. L. Staton, E. M. Gallo, G. R. Crabtree, and L. H. Glimcher. 2009. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10: 306-313.
29. Stanic, A. K., J. S. Bezbradica, J. J. Park, L. Van Kaer, M. R. Boothby, and S. Joyce. 2004. Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. J. Immunol. 172: 4667-4671.
30. Ohteki, T., H. Yoshida, T. Matsuyama, G. S. Duncan, T. W. Mak, and P. S. Ohashi. 1998. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/ beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187: 967-972.
31. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis ofNKandValpha14iNKTcells. Immunity 20: 477-494.
32. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
33. Kim, P. J., S. Y. Pai, M. Brigl, G. S. Besra, J. Gumperz, and I. C. Ho. 2006. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177: 6650-6659.
34. Lacorazza, H. D., Y. Miyazaki, A. Di Cristofano, A. Deblasio, C. Hedvat, J. Zhang, C. Cordon-Cardo, S. Mao, P. P. Pandolfi, and S. D. Nimer. 2002. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17: 437-449.
35. Matsuda, J. L., Q. Zhang, R. Ndonye, S. K. Richardson, A. R. Howell, and L. Gapin. 2006. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 107: 2797-2805.
36. Sivakumar, V., K. J. Hammond, N. Howells, K. Pfeffer, and F. Weih. 2003. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development. J. Exp. Med. 197: 1613-1621.
37. Stanic, A. K., J. S. Bezbradica, J. J. Park, N. Matsuki, A. L. Mora, L. Van Kaer, M. R. Boothby, and S. Joyce. 2004. NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172: 2265-2273.
38. Walunas, T. L., B. Wang, C. R. Wang, and J. M. Leiden. 2000. Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J. Immunol. 164: 2857-2860.
39. Pitcher, L. A., P. S. Ohashi, and N. S. C. van Oers. 2003. T cell antagonism is functionally uncoupled from the 21- and 23-kDa tyrosine-phosphorylated TCR zeta subunits. J. Immunol. 171: 845-852.
40. van Oers, N. S. C., B. Tohlen, B. Malissen, C. R. Moomaw, S. Afendis, and C. A. Slaughter. 2000. The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations. Nat. Immunol. 1: 322-328.
41. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185: 133-140.
42. Cenciarelli, C., D. Hou, K.-C. Hsu, B. L. Rellahan, D. L. Wiest, H. T. Smith, V. A. Fried, and A. M. Weissman. 1992. Activation-induced ubiquitination of the T cell antigen receptor. Science 257: 795-797.
43. Myers, M. D., L. L. Dragone, and A. Weiss. 2005. Src-like adaptor protein down-regulates T cell receptor (TCR)-CD3 expression by targeting TCRzeta for degradation. J. Cell Biol. 170: 285-294.
44. Myers, M. D., T. Sosinowski, L. L. Dragone, C. White, H. Band, H. Gu, and A. Weiss. 2006. Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex. Nat. Immunol. 7: 57-66.
45. Deford-Watts, L. M., T. C. Tassin, A. M. Becker, J. J. Medeiros, J. P. Albanesi, P. E. Love, C. Wülfing, and N. S. van Oers. 2009. The cytoplasmic tail of the T cell receptor CD3 epsilon subunit contains a phospholipid-binding motif that regulates T cell functions. J. Immunol. 183: 1055-1064.
46. Hughes, C. A., C. B. Kodner, and R. C. Johnson. 1992. DNA analysis of Borrelia burgdorferi NCH-1, the first northcentral U.S. human Lyme disease isolate. J. Clin. Microbiol. 30: 698-703.
47. Love, P. E., and E. W. Shores. 2000. ITAM multiplicity and thymocyte selection: how low can you go? Immunity 12: 591-597.
48. Pellicci, D. G., K. J. Hammond, A. P. Uldrich, A. G. Baxter, M. J. Smyth, and D. I. Godfrey. 2002. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
49. Love, P. E., E. W. Shores, E. J. Lee, A. Grinberg, T. I. Munitz, H. Westphal, and A. Singer. 1994. Differential effects of zeta and eta transgenes on early alpha/beta T cell development. J. Exp. Med. 179: 1485-1494.
50. Bezbradica, J. S., T. Hill, A. K. Stanic, L. Van Kaer, and S. Joyce. 2005. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc. Natl. Acad. Sci. USA 102: 5114-5119.
51. Olson, C. M., Jr., T. C. Bates, H. Izadi, J. D. Radolf, S. A. Huber, J. E. Boyson, and J. Anguita. 2009. Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. J. Immunol. 182: 3728-3734.
52. Gadola, S. D., J. D. Silk, A. Jeans, P. A. Illarionov, M. Salio, G. S. Besra, R. Dwek, T. D. Butters, F. M. Platt, and V. Cerundolo. 2006. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203: 2293-2303.
53. Porubsky, S., A. O. Speak, B. Luckow, V. Cerundolo, F. M. Platt, and H. J. Gröne. 2007. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 104: 5977-5982.
54. Schümann, J., F. Facciotti, L. Panza, M. Michieletti, F. Compostella, A. Collmann, L. Mori, and G. De Libero. 2007. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur. J. Immunol. 37: 1431-1441.
55. Speak, A. O., M. Salio, D. C. Neville, J. Fontaine, D. A. Priestman, N. Platt, T. Heare, T. D. Butters, R. A. Dwek, F. Trottein, et al. 2007. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104: 5971-5976.
56. Schümann, J., M. P. Mycko, P. Dellabona, G. Casorati, and H. R. MacDonald. 2006. Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands. J. Immunol. 176: 2064-2068.
57. Wei, D. G., S. A. Curran, P. B. Savage, L. Teyton, and A. Bendelac. 2006. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition. J. Exp. Med. 203: 1197-1207.
58. Becker, A. M., L. M. DeFord-Watts, C. Wuelfing, and N. S. van Oers. 2007. The constitutive tyrosine phosphorylation of CD3zeta results from TCR-MHC interactions that are independent of thymic selection. J. Immunol. 178: 4120-4128.
59. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.
60. Iwabuchi, K., C. Iwabuchi, S. Tone, D. Itoh, N. Tosa, I. Negishi, K. Ogasawara, T. Uede, and K. Onoé. 2001. Defective development of NK1.1+ T-cell antigen receptor alphabeta+ cells in zeta-associated protein 70 null mice with an accumulation of NK1.1+ CD3- NK-like cells in the thymus. Blood 97: 1765-1775.
61. Hou, D., C. Cenciarelli, J. P. Jensen, H. B. Nguygen, and A. M. Weissman. 1994. Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. J. Biol. Chem. 269: 14244-14247.
62. Ma, Y., K. P. Seiler, E. J. Eichwald, J. H. Weis, C. Teuscher, and J. J. Weis. 1998. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 66: 161-168.
63. Brown, C. R., and S. L. Reiner. 1999. Genetic control of experimental lyme arthritis in the absence of specific immunity. Infect. Immun. 67: 1967-1973.
64. Gross, D. M., A. C. Steere, and B. T. Huber. 1998. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160: 1022-1028.
65. Brown, C. R., and S. L. Reiner. 1999. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 67: 3329-3333.
66. Kang, I., S. W. Barthold, D. H. Persing, and L. K. Bockenstedt. 1997. T-helpercell cytokines in the early evolution of murine Lyme arthritis. Infect. Immun. 65: 3107-3111.
67. Barthold, S. W., S. Feng, L. K. Bockenstedt, E. Fikrig, and K. Feen. 1997. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin. Infect. Dis. 25(Suppl 1): S9-S17.
68. Chan, A. Y., J. M. Westcott, J. M. Mooney, E. K. Wakeland, and J. D. Schatzle. 2006. The role of SAP and the SLAM family in autoimmunity. Curr. Opin. Immunol. 18: 656-664.
69. Wandstrat, A. E., C. Nguyen, N. Limaye, A. Y. Chan, S. Subramanian, X. H. Tian, Y. S. Yim, A. Pertsemlidis, H. R. Garner, Jr., L. Morel, and E. K. Wakeland. 2004. Association of extensive polymorphisms in the SLAM/ CD2 gene cluster with murine lupus. Immunity 21: 769-780.